Bipolar disorder stem cells to be deposited with EBiSC
A unique set of stem cells derived from patients with bipolar disorder are to be deposited with the European Bank for Induced Stem Cells (EBiSC). The cell lines were made by researchers from the University of Edinburgh in a project funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) through the CRACK IT Challenge programme. The cell lines are being banked and tested by Roslin Cell Sciences, part of the Censo Biotechnologies Group, which also operates the EBiSC central facility. By depositing these cells with EBiSC they will become available to expert researchers worldwide and enable a better understanding of the disorder and will help develop new treatments.